This author has yet to write their bio.Meanwhile lets just say that we are proud admini contributed a whooping 20 entries.
Entries by admini
Presented at the Society of Toxicology Annual Meeting and ToxExpo in Baltimore, Maryland; March 2019.
Tyrosine kinase inhibitors (TKI) have greatly improved the treatment and prognosis for a wide range of cancers but often cause cardiotoxic effects. We developed an in vitro assay, Cardio quickPredict, for predicting cardiovascular liability based on changes in human iPSC-derived cardiomyocytes (iPSC-CM) metabolism and cell viability, which identifies both functional and structural cardiotoxicants.
Chief Executive Officer, Member of the Board of Directors
Chief Operations Officer, Vice President of Research and Development, Member of the Scientific Advisory Board
Director of Toxicology
Associate Director of Toxicology
Associate Director of Computational Biology
Associate Director of BioAnalytical Technology
Chief Executive Officer
Chairman – Boston HealthCare